<DOC>
	<DOCNO>NCT00239083</DOCNO>
	<brief_summary>The aim MYFORMS ass efficacy safety clinical outcome EC-MPS combination Cyclosporine microemulsion ( CsA-ME ) kidney transplant recipient .</brief_summary>
	<brief_title>Efficacy Safety Enteric-Coated Mycophenolate Sodium ( EC-MPS ) Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>De NovoInclusion criteria 1 . Males female age 6 year . 2 . Recipients cadaveric , live unrelated living relate kidney transplant , treat CsAMe , without corticosteroid , primary immunosuppression . MaintenanceInclusion criteria 1 . Males female age 6 year . 2 . Recipients first secondary cadaveric , live relate unrelated donor kidney transplant . 3 . Patients currently receive CsAME without Mycophenolate mofetil ( MMF ) azathioprine , without corticosteroid part immunosuppressive regimen least 3 month prior Screening . 4 . Patients stable condition term graft function ( serum creatinine 2.3 mg/dL ( =204 Âµmol/L ) screen baseline , increase 20 % baseline compare value obtain screen ) , change immune suppressive regimen due graft malfunction , know clinically significant physical and/or laboratory change least 2 month prior enrollment . De Novo MaintenanceExclusion Criteria 1 . Multiorgan recipient ( e.g . kidney pancreas ) previous transplant organ kidney . 2 . Patients know hypersensitivity MPA , ECMPS component formulation ( e.g . lactose ) . 3 . Patients thrombocytopenia ( &lt; 75,000/mm3 ) , absolute neutrophil count &lt; 1,500/mm3 , and/or leukocytopenia ( &lt; 2,500/mm3 ) , and/or hemoglobin &lt; 6 g/dL Screening Baseline . 4 . Patients history malignancy within last five year , except excise squamous basal cell carcinoma skin . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>MYFORMS , Kidney Transplantation , Enteric-Coated Mycophenolate Sodium ( EC-MPS ) , Cyclosporine microemulsion ( CsA-ME )</keyword>
</DOC>